Shire Buys ViroPharma For $4.2bn - Shire Buys ViroPharma For $4.2bn London-listed pharmaceuticals group says the deal will boost its rare disease unit and generate cost synergies of about $150m by 2015 Source Psychology, Special Needs & Health.